Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle

Journal of Virology

Volumn 88, Issue 9, 2014, Pages 4962-4975

  Chiu, Shih Hsin ^a,b   Wu, Meng Chuan ^a,d   Wu, Chung Chun ^b   Chen, Yu Ching ^b   Lin, Su Fang ^b   Hsu, John T A ^b   Yang, Chung Shi ^b   Tsai, Ching Hwa ^a   Takada, Kenzo ^c   Chen, Mei Ru ^a   Chen, Jen Yang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BALF3 PROTEIN; ENDONUCLEASE; MAGNESIUM; MANGANESE; NUCLEASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA CLEAVAGE; DNA PACKAGING; DNA REPLICATION; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME MECHANISM; EPSTEIN BARR VIRUS; GENE SILENCING; IN VITRO STUDY; LYTIC CYCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS INHIBITION; SEQUENCE HOMOLOGY; VIRION; VIRUS RELEASE; VIRUS REPLICATION;

CATIONS, DIVALENT; ENDONUCLEASES; ENZYME ACTIVATORS; HERPESVIRUS 4, HUMAN; MAGNESIUM; MANGANESE; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84897495549     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00063-14     Document Type: Article

References (90)

1. Nonoyama M, Pagano JS. 1972. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat. New Biol. 238:169-171. http://dx.doi.org/10.1038/newbio238169a0.
2. Nonoyama M, Tanaka A. 1975. Plasmid DNA as a possible state of Epstein-Barr virus genomes in nonproductive cells. Cold Spring Harbor Symp. Quant. Biol. 39:807-810.
3. Adams A, Lindahl T. 1975. Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc. Natl. Acad. Sci. U. S. A. 72:1477-1481. http://dx.doi.org/10.1073/pnas.72.4.1477.
4. Yates J, Warren N, Reisman D, Sugden B. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. U. S. A. 81:3806-3810. http://dx.doi.org/10.1073/pnas.81.12.3806.
5. Yates JL, Warren N, Sugden B. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815. http://dx.doi.org/10.1038/313812a0.
6. Adams A. 1987. Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61:1743-1746.
7. Schepers A, Ritzi M, Bousset K, Kremmer E, Yates JL, Harwood J, Diffley JF, Hammerschmidt W. 2001. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20:4588-4602. http://dx.doi.org/10.1093/emboj/20.16.4588.
8. Chaudhuri B, Xu H, Todorov I, Dutta A, Yates JL. 2001. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. U. S. A. 98:10085-10089. http://dx.doi.org/10.1073/pnas.181347998.
9. Dhar SK, Yoshida K, Machida Y, Khaira P, Chaudhuri B, Wohlschlegel JA, Leffak M, Yates J, Dutta A. 2001. Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106: 287-296. http://dx.doi.org/10.1016/S0092-8674(01)00458-5.
10. Moriyama K, Yoshizawa-Sugata N, Obuse C, Tsurimoto T, Masai H. 2012. Epstein-Barr nuclear antigen 1 (EBNA1)-dependent recruitment of origin recognition complex (Orc) on oriP of Epstein-Barr virus with purified proteins: stimulation by Cdc6 through its direct interaction with EBNA1. J. Biol. Chem. 287:23977-23994. http://dx.doi.org/10.1074/jbc.M112.368456.
11. Hammerschmidt W, Sugden B. 1988. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427-433. http://dx.doi.org/10.1016/0092-8674(88)90028-1.
12. Hammerschmidt W, Sugden B. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397. http://dx.doi.org/10.1038/340393a0.
13. Addison C, Rixon FJ, Preston VG. 1990. Herpes simplex virus type 1 UL28 gene product is important for the formation of mature capsids. J. Gen. Virol. 71:2377-2384. http://dx.doi.org/10.1099/0022-1317-71-10-2377.
14. Poon AP, Roizman B. 1993. Characterization of a temperature-sensitive mutant of the UL15 open reading frame of herpes simplex virus 1. J. Virol. 67:4497-4503.
15. Bogner E, Reschke M, Reis B, Mockenhaupt T, Radsak K. 1993. Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology 196:290-293. http://dx.doi.org/10.1006/viro.1993.1477.
16. Visalli RJ, Nicolosi DM, Irven KL, Goshorn B, Khan T, Visalli MA. 2007. The varicella-zoster virus DNA encapsidation genes: identification and characterization of the putative terminase subunits. Virus Res. 129: 200-211. http://dx.doi.org/10.1016/j.virusres.2007.07.015.
17. Underwood MR, Harvey RJ, Stanat SC, Hemphill ML, Miller T, Drach JC, Townsend LB, Biron KK. 1998. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72:717-725.
18. Tengelsen LA, Pederson NE, Shaver PR, Wathen MW, Homa FL. 1993. Herpes simplex virus type 1 DNA cleavage and encapsidation require the product of the UL28 gene: isolation and characterization of two UL28 deletion mutants. J. Virol. 67:3470-3480.
19. Hwang JS, Bogner E. 2002. ATPase activity of the terminase subunit pUL56 of human cytomegalovirus. J. Biol. Chem. 277:6943-6948. http://dx.doi.org/10.1074/jbc.M108984200.
20. Bogner E, Radsak K, Stinski MF. 1998. The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J. Virol. 72:2259-2264.
21. Baines JD, Poon AP, Rovnak J, Roizman B. 1994. The herpes simplex virus 1 UL15 gene encodes two proteins and is required for cleavage of genomic viral DNA. J. Virol. 68:8118-8124.
22. Scheffczik H, Savva CG, Holzenburg A, Kolesnikova L, Bogner E. 2002. The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucleic Acids Res. 30:1695-1703. http://dx.doi.org/10.1093/nar/30.7.1695.
23. Thoma C, Bogner E. 2010. Short hairpin RNAs specific to human cytomegalovirus terminase subunit pUL89 prevent viral maturation. Antivir. Ther. 15:391-400. http://dx.doi.org/10.3851/IMP1536.
24. Beard PM, Taus NS, Baines JD. 2002. DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells. J. Virol. 76:4785-4791. http://dx.doi.org/10.1128/JVI.76.10.4785-4791.2002.
25. Yang K, Baines JD. 2006. The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. J. Virol. 80:5733-5739. http://dx.doi.org/10.1128/JVI.00125-06.
26. Jacobson JG, Yang K, Baines JD, Homa FL. 2006. Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation. J. Virol. 80:12312-12323. http://dx.doi.org/10.1128/JVI.01766-06.
27. Visalli RJ, Knepper J, Goshorn B, Vanover K, Burnside DM, Irven K, McGauley R, Visalli M. 2009. Characterization of the varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins. Virus Res. 144:58-64. http://dx.doi.org/10.1016/j.virusres.2009.03.019.
28. Borst EM, Kleine-Albers J, Gabaev I, Babic M, Wagner K, Binz A, Degenhardt I, Kalesse M, Jonjic S, Bauerfeind R, Messerle M. 2013. The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89. J. Virol. 87:1720-1732. http://dx.doi.org/10.1128/JVI.01955-12.
29. Wagner MJ, Summers WC. 1978. Structure of the joint region and the termini of the DNA of herpes simplex virus type 1. J. Virol. 27:374-387.
30. Grafstrom RH, Alwine JC, Steinhart WL, Hill CW. 1975. Terminal repetitions in herpes simplex virus type 1 DNA. Cold Spring Harbor Symp. Quant. Biol. 39:679-681.
31. Sheldrick P, Berthelot N. 1975. Inverted repetitions in the chromosome of herpes simplex virus. Cold Spring Harbor Symp. Quant. Biol. 39:667-678.
32. Wadsworth S, Jacob RJ, Roizman B. 1975. Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions. J. Virol. 15:1487-1497.
33. Wadsworth S, Hayward GS, Roizman B. 1976. Anatomy of herpes simplex virus DNA. V. Terminally repetitive sequences. J. Virol. 17:503-512.
34. Varmuza SL, Smiley JR. 1985. Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences. Cell 41:793-802. http://dx.doi.org/10.1016/S0092-8674(85)80060-X.
35. Deiss LP, Chou J, Frenkel N. 1986. Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. J. Virol. 59:605-618.
36. Deiss LP, Frenkel N. 1986. Herpes simplex virus amplicon: cleavage of concatemeric DNA is linked to packaging and involves amplification of the terminally reiterated a sequence. J. Virol. 57:933-941.
37. Mocarski ES, Liu AC, Spaete RR. 1987. Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J. Gen. Virol. 68:2223-2230. http://dx.doi.org/10.1099/0022-1317-68-8-2223.
38. van den Berg FM, van Ooyen AJ, Volkers H, Walboomers JM. 1984. Heterogeneity in subregions of the terminal repeats of herpes simplex virus type 2 DNA. Intervirology 21:96-103. http://dx.doi.org/10.1159/000149507.
39. Spaete RR, Mocarski ES. 1985. The a sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J. Virol. 54:817-824.
40. Albrecht M, Darai G, Flugel RM. 1985. Analysis of the genomic termini of tupaia herpesvirus DNA by restriction mapping and nucleotide sequencing. J. Virol. 56:466-474.
41. Davison AJ. 1984. Structure of the genome termini of varicella-zoster virus. J. Gen. Virol. 65:1969-1977. http://dx.doi.org/10.1099/0022-1317-65-11-1969.
42. Bankier AT, Diertrich W, Baer R, Barrell BG, Colbere-Garapin F, Fleckenstein B, Bodemer W. 1985. Terminal repetitive sequences in herpesvirus saimiri virion DNA. J. Virol. 55:133-139.
43. Marks JR, Spector DH. 1988. Replication of the murine cytomegalovirus genome: structure and role of the termini in the generation and cleavage of concatenates. Virology 162:98-107. http://dx.doi.org/10.1016/0042-6822(88)90398-4.
44. Hammerschmidt W, Ludwig H, Buhk HJ. 1988. Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J. Virol. 62:1355-1363.
45. 2-herpesvirus bovine herpesvirus type 4. J. Gen. Virol. 80:979-986.
46. McVoy MA, Nixon DE, Adler SP, Mocarski ES. 1998. Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J. Virol. 72:48-56.
47. Adelman K, Salmon B, Baines JD. 2001. Herpes simplex virus DNA packaging sequences adopt novel structures that are specifically recognized by a component of the cleavage and packaging machinery. Proc. Natl. Acad. Sci. U. S. A. 98:3086-3091. http://dx.doi.org/10.1073/pnas.061555698.
48. Zimmermann J, Hammerschmidt W. 1995. Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J. Virol. 69:3147-3155.
49. Feederle R, Shannon-Lowe C, Baldwin G, Delecluse HJ. 2005. Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative Epstein-Barr virus. J. Virol. 79:7641-7647. http://dx.doi.org/10.1128/JVI.79.12.7641-7647.2005.
50. Pavlova S, Feederle R, Gartner K, Fuchs W, Granzow H, Delecluse HJ. 2013. An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA. J. Virol. 87:2011-2022. http://dx.doi.org/10.1128/JVI.02533-12.
51. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM. 1990. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab. Invest. 62:713-724.
52. Chang Y, Tung CH, Huang YT, Lu J, Chen JY, Tsai CH. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J. Virol. 73:8857-8866.
53. Lee DF, Chen CC, Hsu TA, Juang JL. 2000. A baculovirus superinfection system: efficient vehicle for gene transfer into Drosophila S2 cells. J. Virol. 74:11873-11880. http://dx.doi.org/10.1128/JVI.74.24.11873-11880.2000.
54. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211. http://dx.doi.org/10.1038/310207a0.
55. Lin SF, Hsu TY, Liu MY, Lin LS, Yang HL, Chen JY, Yang CS. 1995. Characterization of Epstein-Barr virus DNase and its interaction with the major DNA binding protein. Virology 208:712-722. http://dx.doi.org/10.1006/viro.1995.1203.
56. Chen YJ, Tsai WH, Chen YL, Ko YC, Chou SP, Chen JY, Lin SF. 2011. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcomaassociated herpesvirus lytic reactivations in 293 cells. PLoS One 6:e17809. http://dx.doi.org/10.1371/journal.pone.0017809.
57. Baldwin AS, Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681. http://dx.doi.org/10.1146/annurev.immunol.14.1.649.
58. Chang Y, Cheng SD, Tsai CH. 2002. Chromosomal integration of Epstein-Barr virus genomes in nasopharyngeal carcinoma cells. Head Neck 24:143-150. http://dx.doi.org/10.1002/hed.10039.
59. Pulvertaft RJV. 1965. A study of malignant tumours in Nigeria by shortterm tissue culture. J. Clin. Pathol. 18:261-273. http://dx.doi.org/10.1136/jcp.18.3.261.
60. Gardella T, Medveczky P, Sairenji T, Mulder C. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254.
61. Miller G, Shope T, Lisco H, Stitt D, Lipman M. 1972. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. U. S. A. 69:383-387. http://dx.doi.org/10.1073/pnas.69.2.383.
62. Lin Z, Wang X, Strong MJ, Concha M, Baddoo M, Xu G, Baribault C, Fewell C, Hulme W, Hedges D, Taylor CM, Flemington EK. 2013. Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains. J. Virol. 87:1172-1182. http://dx.doi.org/10.1128/JVI.02517-12.
63. Champier G, Couvreux A, Hantz S, Rametti A, Mazeron MC, Bouaziz S, Denis F, Alain S. 2008. Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. Antivir. Ther. 13:643-654.
64. Scholz B, Rechter S, Drach JC, Townsend LB, Bogner E. 2003. Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucleic Acids Res. 31:1426-1433. http://dx.doi.org/10.1093/nar/gkg229.
65. Lu CC, Jeng YY, Tsai CH, Liu MY, Yeh SW, Hsu TY, Chen MR. 2006. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345:358-372. http://dx.doi.org/10.1016/j.virol.2005.09.064.
66. Arrand JR, Rymo L, Walsh JE, Bjorck E, Lindahl T, Griffin BE. 1981. Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res. 9:2999-3014. http://dx.doi.org/10.1093/nar/9.13.2999.
67. Becker A, Gold M. 1978. Enzymatic breakage of the cohesive end site of phage λ DNA: terminase (ter) reaction. Proc. Natl. Acad. Sci. U. S. A. 75:4199-4203. http://dx.doi.org/10.1073/pnas.75.9.4199.
68. Tomka MA, Catalano CE. 1993. Physical and kinetic characterization of the DNA packaging enzyme from bacteriophage λ. J. Biol. Chem. 268: 3056-3065.
69. Higgins RR, Lucko HJ, Becker A. 1988. Mechanism of cos DNA cleavage by bacteriophage λ terminase: multiple roles of ATP. Cell 54:765-775. http://dx.doi.org/10.1016/S0092-8674(88)91021-5.
70. Cue D, Feiss M. 1993. The role of cosB, the binding site for terminase, the DNA packaging enzyme of bacteriophage λ, in the nicking reaction. J. Mol. Biol. 234:594-609. http://dx.doi.org/10.1006/jmbi.1993.1614.
71. Higgins RR, Becker A. 1994. Chromosome end formation in phage λ, catalyzed by terminase, is controlled by twoDNAelements of cos, cosN and R3, and by ATP. EMBO J. 13:6152-6161.
72. Higgins RR, Becker A. 1995. Interaction of terminase, the DNA packaging enzyme of phage λ, with its cosDNAsubstrate. J. Mol. Biol. 252:31-46. http://dx.doi.org/10.1006/jmbi.1995.0473.
73. Becker A, Murialdo H. 1990. Bacteriophage lambda DNA: the beginning of the end. J. Bacteriol. 172:2819-2824.
74. Walker JE, Saraste M, Runswick MJ, Gay NJ. 1982. Distantly related sequences in the α-and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:945-951.
75. Krosky PM, Underwood MR, Turk SR, Feng KW, Jain RK, Ptak RG, Westerman AC, Biron KK, Townsend LB, Drach JC. 1998. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72:4721-4728.
76. Bogner E. 2002. Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev. Med. Virol. 12:115-127. http://dx.doi.org/10.1002/rmv.344.
77. Savva CG, Holzenburg A, Bogner E. 2004. Insights into the structure of human cytomegalovirus large terminase subunit pUL56. FEBS Lett. 563: 135-140. http://dx.doi.org/10.1016/S0014-5793(04)00283-2.
78. Mani M, Smith J, Kandavelou K, Berg JM, Chandrasegaran S. 2005. Binding of two zinc finger nuclease monomers to two specific sites is required for effective double-strand DNA cleavage. Biochem. Biophys. Res. Commun. 334:1191-1197. http://dx.doi.org/10.1016/j.bbrc.2005.07.021.
79. Smith J, Bibikova M, Whitby FG, Reddy AR, Chandrasegaran S, Carroll D. 2000. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28:3361-3369. http://dx.doi.org/10.1093/nar/28.17.3361.
80. Bhattacharyya SP, Rao VB. 1993. A novel terminase activity associated with the DNA packaging protein gp17 of bacteriophage T4. Virology 196: 34-44. http://dx.doi.org/10.1006/viro.1993.1452.
81. Mosig G, Ghosal D, Bock S. 1981. Interactions between the maturation protein gp17 and the single-stranded DNA binding protein gp32 initiate DNA packaging and compete with initiation of secondary DNA replication forks in phage T4. Prog. Clin. Biol. Res. 64:139-150.
82. Koslowski KM, Shaver PR, Casey JT, II, Wilson T, Yamanaka G, Sheaffer AK, Tenney DJ, Pederson NE. 1999. Physical and functional interactions between the herpes simplex virus UL15 and UL28DNAcleavage and packaging proteins. J. Virol. 73:1704-1707.
83. Yang K, Homa F, Baines JD. 2007. Putative terminase subunits of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus. J. Virol. 81:6419-6433. http://dx.doi.org/10.1128/JVI.00047-07.
84. Giesen K, Radsak K, Bogner E. 2000. The potential terminase subunit of human cytomegalovirus, pUL56, is translocated into the nucleus by its own nuclear localization signal and interacts with importin β. J. Gen. Virol. 81:2231-2244.
85. Przech AJ, Yu D, Weller SK. 2003. Point mutations in exon I of the herpes simplex virus putative terminase subunit, UL15, indicate that the most conserved residues are essential for cleavage and packaging. J. Virol. 77: 9613-9621. http://dx.doi.org/10.1128/JVI.77.17.9613-9621.2003.
86. Nyormoi O, Thorley-Lawson DA, Elkington J, Strominger JL. 1976. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. Proc. Natl. Acad. Sci. U. S. A. 73:1745-1748. http://dx.doi.org/10.1073/pnas.73.5.1745.
87. Summers WC, Klein G. 1976. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. J. Virol. 18: 151-155.
88. Tsai CH, Williams MV, Glaser R. 1991. Characterization of two monoclonal antibodies to Epstein-Barr virus diffuse early antigen which react to two different epitopes and have different biological function. J. Virol. Methods 33:47-52.
89. Newcomb WW, Homa FL, Brown JC. 2006. Herpes simplex virus capsid structure: DNA packaging protein UL25 is located on the external surface of the capsid near the vertices. J. Virol. 80:6286-6294. http://dx.doi.org/10.1128/JVI.02648-05.
90. Nellissery JK, Szczepaniak R, Lamberti C, Weller SK. 2007. A putative leucine zipper within the herpes simplex virus type 1 UL6 protein is required for portal ring formation. J. Virol. 81:8868-8877. http://dx.doi.org/10.1128/JVI.00739-07.